Biohaven Ltd
XNYS:BHVN 4:00:00 PM EDT
| Market Cap (Intraday) | 1.57B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $16.70 |
| 50-Day MA | $15.58 |
| 200-Day MA | $20.86 |
Biohaven Ltd Stock, XNYS:BHVN
215 Church Street, New Haven, Connecticut 06510
United States of America
Phone: +1.203.404.0410
Number of Employees: 256
Description
Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.